Bill Sponsor
House Bill 1750
119th Congress(2025-2026)
HEARD Act of 2025
Introduced
Introduced
Introduced in House on Feb 27, 2025
Overview
Text
Introduced
Feb 27, 2025
Latest Action
Feb 27, 2025
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1750
Congress
119
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Washington
Democrat
District of Columbia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Health Equity and Rare Disease Act of 2025 or the HEARD Act of 2025

This bill establishes Department of Health and Human Services (HHS) grants and other initiatives to address rare diseases or conditions (e.g., those affecting less than 200,000 people in the United States) in racial and ethnic minority populations. 

For example, to advance such purposes, the bill establishes within HHS

  • grants to public and private nonprofit entities for data collection and public outreach,
  • grants to health professions schools to improve health care and minority representation in research regarding rare diseases and conditions,
  • grants to tribal epidemiology centers and tribal and urban Indian health centers for research regarding rare diseases and conditions in tribal communities,
  • scholarships and educational loan repayment for medical school students who agree to work as health care professionals serving populations with rare diseases or conditions,
  • initiatives to coordinate research and other activities across the National Institutes of Health, and
  • public health awareness and education campaigns.

Also, the bill requires HHS to submit various reports to Congress on topics including (1) the federal government’s research and public health activities regarding rare diseases or conditions in minority populations, (2) regulatory barriers to treating rare diseases in Medicare beneficiaries of color, and (3) strategies for research and development of treatments for rare diseases or conditions that disproportionately impact minority populations.

Text (1)
February 27, 2025
Actions (2)
02/27/2025
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
02/27/2025
Introduced in House
Public Record
Record Updated
Oct 8, 2026 2:58:19 PM